drugset
drugset / Trial / NCT02414776

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy

NCT02414776 ↗

Phase 1 Terminated 3 enrolled Western Regional Medical Center
NaSingle-groupOpen-labelTreatment

Summary

To determine the safety and tolerability of orally administered hydroxychloroquine with hormonal therapy. To assess the response rate of hydroxychloroquine in combination with hormonal therapy.

Timeline

Start
2014-07
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule — Oral

Indications

estrogen-receptor positive breast cancer